Small intestine cancer natural history, complications, and prognosis: Difference between revisions
No edit summary |
|||
(7 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Small intestine cancer}} | {{Small intestine cancer}} | ||
{{CMG}}{{AE}}{{Qurrat}} {{PSD}} | {{CMG}}; {{AE}}{{Qurrat}}, {{PSD}} | ||
==Overview== | ==Overview== | ||
Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor. Small intestine adenocarcinoma is associated with a 5 year survival rate of 20%. | Clinical features and natural history of small intestinal tumors have not been clearly studied, as its a rare condition. Depending on the extent of the tumor at the time of diagnosis, the [[prognosis]] may vary. However, the [[prognosis]] is generally regarded as poor. [[Small intestine]] [[adenocarcinoma]] is associated with a 5 year [[survival rate]] of 20%. | ||
==Natural History== | ==Natural History== | ||
*Although primary adenocarcinoma is the most common type of small intestine cancer, there is no known pattern of its natural history.<ref name="pmid18997182">{{cite journal |vauthors=Hong SH, Koh YH, Rho SY, Byun JH, Oh ST, Im KW, Kim EK, Chang SK |title=Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome |journal=Jpn. J. Clin. Oncol. |volume=39 |issue=1 |pages=54–61 |date=January 2009 |pmid=18997182 |doi=10.1093/jjco/hyn122 |url=}}</ref> | *Clinical features and natural history of small intestinal tumors have not been clearly studied, as its a rare condition.<ref name="pmid20871040">{{cite journal |vauthors=Higashi D, Ishibashi Y, Tamura T, Nii K, Egawa Y, Koga M, Tomiyasu T, Harimura T, Tanaka R, Futatsuki R, Noda S, Futami K, Maekawa T, Takaki Y, Hirai F, Matsui T |title=Clinical features of and chemotherapy for cancer of the small intestine |journal=Anticancer Res. |volume=30 |issue=8 |pages=3193–7 |date=August 2010 |pmid=20871040 |doi= |url=}}</ref> | ||
*Natural history of carcinoid tumors depends on several factors: | *Although, primary [[adenocarcinoma]] is the most common type of small intestine cancer, there is no known pattern of its [[Natural history of disease|natural history]].<ref name="pmid18997182">{{cite journal |vauthors=Hong SH, Koh YH, Rho SY, Byun JH, Oh ST, Im KW, Kim EK, Chang SK |title=Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome |journal=Jpn. J. Clin. Oncol. |volume=39 |issue=1 |pages=54–61 |date=January 2009 |pmid=18997182 |doi=10.1093/jjco/hyn122 |url=}}</ref> | ||
*[[Natural history of disease|Natural history]] of [[carcinoid tumors]] depends on several factors:<ref name="pmid7698535">{{cite journal |vauthors=Creutzfeldt W |title=Historical background and natural history of carcinoids |journal=Digestion |volume=55 Suppl 3 |issue= |pages=3–10 |date=1994 |pmid=7698535 |doi=10.1159/000201195 |url=}}</ref> | |||
**Size | **Size | ||
**Site of origin | **Site of origin | ||
**Growth pattern | **Growth pattern | ||
**Hormone dependence | **Hormone dependence | ||
**Neuropeptides and amines expressed by a carcinoid | **[[Neuropeptide|Neuropeptides]] and [[Amine|amines]] expressed by a [[Carcinoid syndrome|carcinoid]] | ||
**Amount of biologically active neuro-hormones secreted | **Amount of biologically active neuro-hormones secreted | ||
==Complications== | ==Complications== | ||
*[[Small intestine]] cancer are diagnosed in advance stage due to absence of specific symptoms and suspicion. | |||
*Most complications appear after the resection of the tumor post-operatively.<ref name="pmid28486220">{{cite journal |vauthors=Wang XJ, Chi P, Lin HM, Lu XR, Huang Y, Xu ZB, Huang SH, Sun YW, Ye DX |title=Risk Factors for Early Postoperative Small Bowel Obstruction after Elective Colon Cancer Surgery: An Observational Study of 1,244 Consecutive Patients |journal=Dig Surg |volume=35 |issue=1 |pages=49–54 |date=2018 |pmid=28486220 |doi=10.1159/000468155 |url=}}</ref> | |||
*When tumor grow larger to obstruct the lumen of intestine symptoms of [[constipation]] and obstruction appear. | |||
*Tumor may invade vessels of intestine and may lead to [[melena]] and [[hemorrhage]]. | |||
==Prognosis== | ==Prognosis== | ||
*The overall 5-year survival rate for resectable adenocarcinoma is only 20%. The 5-year survival rate for resectable leiomyosarcoma, the most common primary sarcoma of the small intestine, is approximately 50%. | *The overall 5-year [[survival rate]] for resectable [[adenocarcinoma]] is only 20%. The 5-year survival rate for resectable [[leiomyosarcoma]], the most common primary [[sarcoma]] of the [[small intestine]], is approximately 50%. | ||
*The prognosis of small intestine cancer depends on the following: | *The [[prognosis]] of [[small intestine]] cancer depends on the following: | ||
**Whether or not the [[tumor]] can be removed by [[surgery]]. | **Whether or not the [[tumor]] can be removed by [[surgery]]. | ||
**The stage of the cancer, the size of the tumor, whether the cancer has spread outside the [[small intestine]]. | **The stage of the cancer, the size of the tumor, whether the cancer has spread outside the [[small intestine]]. | ||
**The patient’s general health. | **The patient’s general health. | ||
**Whether the cancer has just been diagnosed or has recurred. | **Whether the cancer has just been diagnosed or has recurred. | ||
*Adenocarcinoma of the duodenum is associated with low overall survival rate compared to the tumors located in jejunum and ileum.<ref name="pmid15274064">{{cite journal |vauthors=Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J |title=Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients |journal=Cancer |volume=101 |issue=3 |pages=518–26 |date=August 2004 |pmid=15274064 |doi=10.1002/cncr.20404 |url=}}</ref> | *[[Adenocarcinoma]] of the [[duodenum]] is associated with low overall [[survival rate]] compared to the [[tumors]] located in [[jejunum]] and [[ileum]].<ref name="pmid15274064">{{cite journal |vauthors=Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J |title=Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients |journal=Cancer |volume=101 |issue=3 |pages=518–26 |date=August 2004 |pmid=15274064 |doi=10.1002/cncr.20404 |url=}}</ref> | ||
==References== | ==References== |
Latest revision as of 21:39, 14 January 2019
Small intestine cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Small intestine cancer natural history, complications, and prognosis On the Web |
American Roentgen Ray Society Images of Small intestine cancer natural history, complications, and prognosis |
FDA on Small intestine cancer natural history, complications, and prognosis |
CDC on Small intestine cancer natural history, complications, and prognosis |
Small intestine cancer natural history, complications, and prognosis in the news |
Blogs on Small intestine cancer natural history, complications, and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Parminder Dhingra, M.D. [3]
Overview
Clinical features and natural history of small intestinal tumors have not been clearly studied, as its a rare condition. Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor. Small intestine adenocarcinoma is associated with a 5 year survival rate of 20%.
Natural History
- Clinical features and natural history of small intestinal tumors have not been clearly studied, as its a rare condition.[1]
- Although, primary adenocarcinoma is the most common type of small intestine cancer, there is no known pattern of its natural history.[2]
- Natural history of carcinoid tumors depends on several factors:[3]
- Size
- Site of origin
- Growth pattern
- Hormone dependence
- Neuropeptides and amines expressed by a carcinoid
- Amount of biologically active neuro-hormones secreted
Complications
- Small intestine cancer are diagnosed in advance stage due to absence of specific symptoms and suspicion.
- Most complications appear after the resection of the tumor post-operatively.[4]
- When tumor grow larger to obstruct the lumen of intestine symptoms of constipation and obstruction appear.
- Tumor may invade vessels of intestine and may lead to melena and hemorrhage.
Prognosis
- The overall 5-year survival rate for resectable adenocarcinoma is only 20%. The 5-year survival rate for resectable leiomyosarcoma, the most common primary sarcoma of the small intestine, is approximately 50%.
- The prognosis of small intestine cancer depends on the following:
- Whether or not the tumor can be removed by surgery.
- The stage of the cancer, the size of the tumor, whether the cancer has spread outside the small intestine.
- The patient’s general health.
- Whether the cancer has just been diagnosed or has recurred.
- Adenocarcinoma of the duodenum is associated with low overall survival rate compared to the tumors located in jejunum and ileum.[5]
References
- ↑ Higashi D, Ishibashi Y, Tamura T, Nii K, Egawa Y, Koga M, Tomiyasu T, Harimura T, Tanaka R, Futatsuki R, Noda S, Futami K, Maekawa T, Takaki Y, Hirai F, Matsui T (August 2010). "Clinical features of and chemotherapy for cancer of the small intestine". Anticancer Res. 30 (8): 3193–7. PMID 20871040.
- ↑ Hong SH, Koh YH, Rho SY, Byun JH, Oh ST, Im KW, Kim EK, Chang SK (January 2009). "Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome". Jpn. J. Clin. Oncol. 39 (1): 54–61. doi:10.1093/jjco/hyn122. PMID 18997182.
- ↑ Creutzfeldt W (1994). "Historical background and natural history of carcinoids". Digestion. 55 Suppl 3: 3–10. doi:10.1159/000201195. PMID 7698535.
- ↑ Wang XJ, Chi P, Lin HM, Lu XR, Huang Y, Xu ZB, Huang SH, Sun YW, Ye DX (2018). "Risk Factors for Early Postoperative Small Bowel Obstruction after Elective Colon Cancer Surgery: An Observational Study of 1,244 Consecutive Patients". Dig Surg. 35 (1): 49–54. doi:10.1159/000468155. PMID 28486220.
- ↑ Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J (August 2004). "Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients". Cancer. 101 (3): 518–26. doi:10.1002/cncr.20404. PMID 15274064.